Aflac Incorporated (NYSE:AFL) Shares Sold by Indiana Trust & Investment Management Co

Indiana Trust & Investment Management Co cut its position in shares of Aflac Incorporated (NYSE:AFL) by 1.9% during the 4th quarter, according to the company in its most recent filing with the SEC. The firm owned 11,686 shares of the financial services provider’s stock after selling 230 shares during the quarter. Indiana Trust & Investment Management Co’s holdings in Aflac were worth $1,209,000 as of its most recent filing with the SEC.

Other hedge funds and other institutional investors also recently modified their holdings of the company. International Assets Investment Management LLC grew its stake in shares of Aflac by 10,878.5% in the 3rd quarter. International Assets Investment Management LLC now owns 559,903 shares of the financial services provider’s stock worth $62,597,000 after purchasing an additional 554,803 shares during the last quarter. Healthcare of Ontario Pension Plan Trust Fund boosted its holdings in Aflac by 471.4% during the third quarter. Healthcare of Ontario Pension Plan Trust Fund now owns 600,000 shares of the financial services provider’s stock worth $67,080,000 after buying an additional 495,000 shares in the last quarter. Assenagon Asset Management S.A. increased its holdings in shares of Aflac by 670.9% in the fourth quarter. Assenagon Asset Management S.A. now owns 556,576 shares of the financial services provider’s stock valued at $57,572,000 after buying an additional 484,378 shares in the last quarter. World Investment Advisors LLC acquired a new stake in shares of Aflac during the 3rd quarter valued at $42,290,000. Finally, Franklin Resources Inc. boosted its stake in shares of Aflac by 75.2% during the 3rd quarter. Franklin Resources Inc. now owns 776,131 shares of the financial services provider’s stock worth $88,533,000 after acquiring an additional 333,083 shares in the last quarter. Institutional investors own 67.44% of the company’s stock.

Aflac Price Performance

AFL opened at $103.09 on Wednesday. The stock has a fifty day moving average price of $104.49 and a 200 day moving average price of $107.02. The company has a current ratio of 0.10, a quick ratio of 0.08 and a debt-to-equity ratio of 0.29. Aflac Incorporated has a 1 year low of $77.01 and a 1 year high of $115.50. The stock has a market cap of $57.27 billion, a price-to-earnings ratio of 10.74, a PEG ratio of 2.10 and a beta of 0.99.

Aflac (NYSE:AFL) last announced its quarterly earnings results on Wednesday, February 5th. The financial services provider reported $1.56 earnings per share (EPS) for the quarter, missing the consensus estimate of $1.63 by ($0.07). Aflac had a net margin of 28.76% and a return on equity of 16.20%. Analysts forecast that Aflac Incorporated will post 6.95 EPS for the current fiscal year.

Aflac Increases Dividend

The business also recently announced a quarterly dividend, which will be paid on Monday, March 3rd. Shareholders of record on Wednesday, February 19th will be given a dividend of $0.58 per share. The ex-dividend date of this dividend is Wednesday, February 19th. This represents a $2.32 dividend on an annualized basis and a yield of 2.25%. This is a boost from Aflac’s previous quarterly dividend of $0.50. Aflac’s dividend payout ratio is presently 20.83%.

Wall Street Analyst Weigh In

AFL has been the topic of a number of recent analyst reports. Evercore ISI cut their target price on Aflac from $104.00 to $102.00 and set an “underperform” rating on the stock in a research report on Wednesday, December 4th. JPMorgan Chase & Co. upped their price objective on shares of Aflac from $90.00 to $94.00 and gave the company a “neutral” rating in a research note on Tuesday, January 7th. Truist Financial raised their target price on shares of Aflac from $100.00 to $105.00 and gave the stock a “hold” rating in a report on Friday, November 1st. Keefe, Bruyette & Woods reduced their price target on shares of Aflac from $108.00 to $107.00 and set a “market perform” rating for the company in a research report on Friday, January 10th. Finally, StockNews.com lowered shares of Aflac from a “hold” rating to a “sell” rating in a research note on Thursday, February 6th. Three investment analysts have rated the stock with a sell rating, ten have assigned a hold rating and two have assigned a buy rating to the stock. According to MarketBeat, Aflac presently has an average rating of “Hold” and an average price target of $103.21.

Insider Buying and Selling

In related news, EVP Audrey B. Tillman sold 24,744 shares of the business’s stock in a transaction dated Friday, December 27th. The stock was sold at an average price of $103.40, for a total transaction of $2,558,529.60. Following the completion of the transaction, the executive vice president now owns 222,618 shares of the company’s stock, valued at approximately $23,018,701.20. The trade was a 10.00 % decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this hyperlink. 0.90% of the stock is owned by insiders.

Aflac Profile

Aflac Incorporated, through its subsidiaries, provides supplemental health and life insurance products. The company operates through Aflac Japan and Aflac U.S. segments. The Aflac Japan segment offers cancer, medical, nursing care, work leave, GIFT, and whole and term life insurance products, as well as WAYS and child endowment plans under saving type insurance products in Japan.